Clinical Trial Update: Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a mycophenolate-based therapy for kidney transplant recipients without HLA-DQ mismatch; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Kidney Transplantation | Phase 4 | Status: RECRUITING